SHOX2 and cutaneous melanoma: However, SHOX2 mRNA expression was lower in breast invasive carcinoma (BRCA), acute myeloid leukemia (LAML), testicular germ cell tumors (TGCT), skin cutaneous melanoma (SKCM) and thyroid carcinoma (THCA) (Fig. 1A).